Mirum Pharmaceuticals, Inc. - common stock (MIRM) Social Stream
Mirum Pharmaceuticals Inc (MIRM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Mirum Pharmaceuticals Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 18 months, MIRM's average price target has gone up $23.
Over the past 18 months, MIRM's average upside potential has been 186.98%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MIRM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MIRM's average broker recommendation rating improved by 0.33 over the prior 16 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- MIRM has a higher upside potential (average analyst target price relative to current price) than 183.89% of all US stocks.
- Mirum Pharmaceuticals Inc's variance in analysts' estimates is lower than -83.11% of all US stocks.
- MIRM has a greater average analyst price target than 178.13% of stocks in the small market cap category.
- The number of analysts covering the stock of MIRM is greater than 66.46% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Mirum Pharmaceuticals Inc are ALGS, GERN and EFTR.
Make investment decisions regarding MIRM using the data that counts. Try POWR Ratings for free.